Tyers Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$2.92M Buy
12,180
+5,320
+78% +$1.46M 0.1% 177
2019
Q2
$1.94M Sell
6,860
-13,048
-66% -$3.56M 0.07% 231
2019
Q1
$5.71M Sell
19,908
-2,660
-12% -$769K 0.2% 104
2018
Q4
$5.93M Sell
22,568
-8,456
-27% -$2.33M 0.24% 91
2018
Q3
$8.5M Sell
31,024
-37,464
-55% -$9.73M 0.28% 78
2018
Q2
$16.3M Sell
68,488
-37,520
-35% -$8.69M 0.56% 44
2018
Q1
$23.3M Buy
106,008
+20,356
+24% +$4.78M 0.82% 33
2017
Q4
$19.3M Buy
85,652
+35,952
+72% +$7.66M 0.68% 39
2017
Q3
$9.44M Buy
49,700
+14,672
+42% +$2.79M 0.35% 71
2017
Q2
$6.59M Buy
35,028
+13,048
+59% +$2.34M 0.24% 92
2017
Q1
$3.63M Buy
21,980
+1,344
+7% +$214K 0.14% 141
2016
Q4
$2.97M Buy
+20,636
New +$2.76M 0.13% 144

Other funds holding ELV

Tyers Asset Management's ELV Position: Q3 2019 in Review

Tyers Asset Management increased its Elevance Health (ELV) stake by 78% in Q3 2019, buying an estimated $1.46M and bringing the position to 12,180 shares worth $2.92M. The position accounts for 0.1% of the portfolio, ranked #177.

Tyers Asset Management first reported a position in ELV in Q4 2016 and has held it in 12 quarters since. The position peaked at $23.3M in Q1 2018. 1,015 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

  • Tyers Asset Management held 12,180 shares of Elevance Health worth $2.92M as of Q3 2019.
  • Tyers Asset Management bought 5,320 Elevance Health shares in Q3 2019, an estimated $1.46M.
  • Elevance Health made up 0.1% of Tyers Asset Management's portfolio in Q3 2019, its #177 holding.
  • Tyers Asset Management first reported a position in Elevance Health in Q4 2016 and has held it in 12 quarters since.
  • Tyers Asset Management's Elevance Health position peaked at $23.3M in Q1 2018.
  • 1,015 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.